The biotech industry is growing as a result of increased research funding, expanded biotechnology applications in healthcare and agriculture, innovative therapies, and collaborations among academia, government, and private companies.
Given the industry’s growth prospects, fundamentally strong biotech ANI Pharmaceuticals, Inc. (ANIP), Vanda Pharmaceuticals Inc. (VNDA), and Corcept Therapeutics Incorporated (CORT) might be worth buying.
